683 Capital discloses 4.67% stake in Modular Medical
Modular Medical, Inc. reports that 683 Capital Partners, LP (through its manager 683 Capital Management, LLC and Managing Member Ari Zweiman) beneficially owned 125,001 common shares and warrants exercisable for 134,239 shares.
Rhea-AI Filing Summary
Modular Medical, Inc. reports that 683 Capital Partners, LP (through its manager 683 Capital Management, LLC and Managing Member Ari Zweiman) beneficially owned 125,001 common shares and warrants exercisable for 134,239 shares. The filing states this position represents approximately 4.67% of the outstanding common stock, based on 5,411,177 shares outstanding as of April 21, 2026, with the 4.67% figure given as of May 15, 2026.
Positive
- None.
Negative
- None.
Insights
Ownership disclosure shows a sub-5% position including exercisable warrants.
The filing details that 125,001 shares are held and 134,239 shares are issuable upon exercise of currently exercisable warrants, and it calculates ownership using 5,411,177 shares outstanding as of April 21, 2026.
Subsequent filings or transactions would change the percentage; the cash‑flow treatment or intent for the warrants is not described in the excerpt.
Schedule 13G/A properly attributes beneficial ownership across manager and managing member.
The disclosure explains that 683 Capital Management, LLC and Ari Zweiman may be deemed beneficial owners of the shares and exercisable warrants held by 683 Capital Partners, LP, consistent with group attribution rules.
Filing signatures show authorization by Ari Zweiman on May 15, 2026; any changes in holdings should be reported in amended schedules.
Key Figures
Key Terms
beneficially owned regulatory
warrants exercisable financial
Schedule 13G/A regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does 683 Capital Partners report in Modular Medical (MODD)?
Are the warrants exercisable or merely issuable in this disclosure?
When was the Schedule 13G/A signed and by whom?
AI-generated analysis. How Rhea-AI works. Not financial advice.